ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1246

The Effect of Tocilizumab on miR-146a-5p and EMMPRIN/CD147 in Rheumatoid Arthritis Patients

Devy Zisman1, Mirna Safieh1, Elina Simanovich1, Joy Feld2, Amalia Kinarty1, Liron Zisman1, Tal Gazitt3, Amir Haddad4, Muna Elias1, Itzhak Rosner5, Lisa Kaly6 and Michal A Rahat7, 1Carmel Medical Center, Haifa, Israel, 2Carmel and Zvulun Medical Centre, Haifa, Israel, 3Carmel Hospital, Haifa, Israel, 4Carmel Medical Centre, Haifa, Israel, 5Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel, 6Bnei Zion Medical Center, Haifa, Israel, 7Carmel Medical Center/Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Meeting: ACR Convergence 2021

Keywords: Angiogenesis, Emmprin, miR-146a-5p, rheumatoid arthritis, Tocilizumab

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Session Title: RA – Treatments Poster II: PROs, Biomarkers, & Systemic Inflammation (1223–1256)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Angiogenesis is an important contributor to the development of rheumatoid arthritis (RA). Tocilizumab (TCZ), an anti-IL-6 receptor antibody used in the treatment of RA patients, has been shown to exert anti-inflammatory effects. However, its effects on angiogenesis are not fully elucidated, and the molecular mechanisms regulating this effect are unknown.
We aimed to evaluate the expression levels of several microRNA molecules and the concentrations of pro- and anti-angiogenic factors in sera of RA patients before and after the initiation of TCZ treatment and to explore the mechanisms of TCZ action in an in vitro co-culture system.

Methods: Sera from 40 RA patients before and 4 months after the initiation of TCZ treatment were collected. Using commercial ELISA kits, the concentrations of the pro-angiogenic factors EMMPRIN, VEGF, MMP-9, IL-6, NGAL, and of the anti-angiogenic factors endostatin and thrombospondin-1 (Tsp-1) were measured, as were the expression levels of microRNA molecules miR-16-5p, miR-21-5p, miR-132-3p, miR-146a-5p, miR-150-5p, miR-155-5p, miR-203a-3p, miR-221-3p, and miR-323a-3p. In vitro, the levels of secreted EMMPRIN, VEGF MMP-9 and Tsp-1 were measured in a co-culture system of HT1080 fibroblasts and U937 monocytes with and without addition of anti-EMMPRIN blocking antibody.

Results: The mean age of RA patients was 57.5±11.1 years, 33 (82.5%) females, mean disease duration 7.7±5.6 years. Of these patients, 25/40 (62.5%) were classified as “responders” based on EULAR criteria.

Statistically significant reduction in the level of EMMPRIN/CD147 (p=0.035), without significant changes in serum levels of MMP-9, VEGF, MMP-3, MMP-7 and of the anti-angiogenic factors Tsp-1 and endostatin were found 4 months after TCZ treatment. The ratio between EMMPRIN and Tsp-1 calculated for each patient 4 months after initiating TCZ decreased significantly (p=0.031), most notably in responding patients versus non-responders (p=0.033), while the levels of VEGF, MMP-9, Tsp-1, and EMMPRIN were unchanged. Of microRNA, only miR-146a-5p and miR-150-5p levels were significantly increased after 4 months of TCZ treatment relative to treatment initiation (p=0.0178, p=0.0028 respectively), with no difference noted in microRNA levels between patients considered responders and non-responders to TCZ.

In vitro, the accumulation of EMMRPIN, VEGF and MMP-9 in the supernatants was increased by co-culturing the HT1080 fibroblasts and the U937 monocytes (p< 0.05, p< 0.05, P< 0.001 respectively), while the accumulation of the anti-angiogenic factor thrombospondin-1 (Tsp-1) (p< 0.001) and the expression levels of miR-146a-5p were reduced (p< 0.001). Transfection of the miR-146-5p mimic reduced EMMPRIN, VEGF and MMP-9 levels by 1.3, 2.3 and 2.2-fold, respectively (p< 0.05).

Adding anti-EMMPRIN antibody to the co-culture reduced the accumulation of VEGF and MMP-9 in the supernatants by 1.8 and 1.4, respectively (p< 0.05).

Conclusion: Our findings implicate miR-146a-5p in the regulation of EMMPRIN and suggest that TCZ affects angiogenesis through its effects on EMMRPIN and miR-146a-5p.


Disclosures: D. Zisman, None; M. Safieh, None; E. Simanovich, None; J. Feld, None; A. Kinarty, None; L. Zisman, None; T. Gazitt, None; A. Haddad, None; M. Elias, None; I. Rosner, None; L. Kaly, None; M. Rahat, None.

To cite this abstract in AMA style:

Zisman D, Safieh M, Simanovich E, Feld J, Kinarty A, Zisman L, Gazitt T, Haddad A, Elias M, Rosner I, Kaly L, Rahat M. The Effect of Tocilizumab on miR-146a-5p and EMMPRIN/CD147 in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-tocilizumab-on-mir-146a-5p-and-emmprin-cd147-in-rheumatoid-arthritis-patients/. Accessed May 25, 2022.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-tocilizumab-on-mir-146a-5p-and-emmprin-cd147-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.